IP Verse

Oral Pharmaceutical Composition

Patent No. EP2815752 (titled "Oral Pharmaceutical Composition") was filed by Taiho Pharmaceutical on Feb 14, 2013. The application was issued on May 20, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSFeb 19, 2021LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2815752

TAIHO PHARMACEUTICAL
Application Number
EP13749905A
Filing Date
Feb 14, 2013
Status
Granted And Under Opposition
Apr 17, 2020
Publication Date
May 20, 2020
External Links
Slate, EP2815752B1, Google Patents